Model DetailsLung tumor
Model Name |
Lung tumor | Strain |
CD-1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
bronchiolo-alveolar adenoma or carcinoma • lung, bronchiolar/alveolar adenoma/carcinoma • lung neoplasm • lung tumor • pulmonary neoplasm |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
---|---|---|---|---|---|
Lung | Male |
12% |
17-24 months |
|
Newbold RR, Carcinogenesis 2000 Jul;21(7):1355-63 |
Lung | Male |
20% (12 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
Lung | Male |
13% (8 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
Lung | Female |
18% (11 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
Lung | Female |
15% (9 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
Lung | Male |
6.4% (2 of 31 mice) |
180-400 days |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Lung | Male |
25% (4 of 16 mice) |
401 - ~725 days |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Lung | Male |
60% (3 of 5 mice) |
~730 days |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Lung | Male |
33.3% (7 of 21 mice) |
>400 days |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Lung | Male |
17.3% (9 of 52 mice) |
>180 days |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Lung | Female |
12.9% (4 of 31 mice) |
180-400 days |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Lung | Female |
0% (0 of 12 mice) |
401 - ~725 days |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Lung | Female |
36.4% (4 of 11 mice) |
~730 days |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Lung | Female |
17.4% (4 of 23 mice) |
>400 days |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Lung | Female |
14.8% (8 of 54 mice) |
>180 days |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
Lung | Female |
observed |
≥1 year |
|
Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 |
Lung | Male |
observed |
≥1 year |
|
Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 |